Cytotoxic chemotherapy genetic anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Cell Line, Tumor T-Lymphocytes, Cytotoxic Tumor Cells, Cultured Bone Marrow Cell Line Cells, Cultured K562 Cells HT29 Cells HCT116 Cells HL-60 Cells

Organisms4

Mice, Nude Mice, Inbred BALB C Mice, Inbred C57BL Mice, SCID

Diseases50

Neoplasms Radiation Injuries Breast Neoplasms Lung Neoplasms Neoplasm Recurrence, Local Neutropenia Ovarian Neoplasms Lymphoma, Non-Hodgkin Neoplasm Metastasis Carcinoma, Non-Small-Cell Lung Brain Neoplasms Acneiform Eruptions Adenocarcinoma Lymphoma Leukemia, Myeloid, Acute Liver Neoplasms Thrombocytopenia Radiation Pneumonitis Radiation Injuries, Experimental Disease Progression Prostatic Neoplasms Neoplasms, Radiation-Induced Multiple Myeloma Recurrence Colonic Neoplasms Neovascularization, Pathologic Neoplasms, Experimental Carcinoma, Squamous Cell Colorectal Neoplasms Head and Neck Neoplasms Hodgkin Disease Carcinoma Osteosarcoma Bone Neoplasms Testicular Neoplasms Melanoma Vomiting Nausea Glioma Stomach Neoplasms Pancreatic Neoplasms Glioblastoma Leukemia P388 Leukemia Acute Radiation Syndrome Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukopenia Lymphatic Metastasis Neoplasms, Germ Cell and Embryonal Sarcoma

Chemicals and Drugs85

Antineoplastic Agents Doxorubicin Cisplatin Cyclophosphamide Etoposide Antibiotics, Antineoplastic Paclitaxel Antineoplastic Agents, Phytogenic Methotrexate Angiogenesis Inhibitors Antimetabolites, Antineoplastic Deoxycytidine Organoplatinum Compounds Taxoids Mitoxantrone Antibodies, Monoclonal, Humanized Antibodies, Monoclonal Dacarbazine Fluorouracil Vincristine Vinblastine Camptothecin Protein Kinase Inhibitors Antineoplastic Agents, Alkylating Carboplatin Niacinamide Bleomycin Drug Carriers Benzenesulfonates Tumor Markers, Biological Radiation-Sensitizing Agents Granulocyte Colony-Stimulating Factor P-Glycoprotein Daunorubicin Phenylurea Compounds Quinazolines Anthracyclines Recombinant Proteins Ellipticines Platinum Mitomycin Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents, Hormonal Cytarabine Tamoxifen Ifosfamide Receptor, Epidermal Growth Factor Prodrugs Pore Forming Cytotoxic Proteins Tumor Suppressor Protein p53 Plant Extracts Platinum Compounds Enzyme Inhibitors Cytotoxins DNA Topoisomerases, Type II Carmustine Radiation-Protective Agents Neoplasm Proteins Proto-Oncogene Proteins c-bcl-2 Topoisomerase I Inhibitors Melphalan Caspases Caspase 3 DNA Nimustine Chlorambucil Lomustine Floxuridine Tegafur Multidrug Resistance-Associated Proteins Adjuvants, Pharmaceutic Nanocapsules RNA, Messenger Topoisomerase II Inhibitors Topotecan Teniposide Mitomycins Antigens, Neoplasm Razoxane Cobalt Radioisotopes DNA-Binding Proteins RNA, Small Interfering Intercalating Agents ATP-Binding Cassette Transporters Drugs, Investigational

Analytical, Diagnostic and Therapeutic Techniques and Equipment70

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Combined Modality Therapy Radiation Dosage Treatment Outcome Drug Screening Assays, Antitumor Dose-Response Relationship, Radiation Clinical Trials as Topic Disease-Free Survival Drug Administration Schedule Prognosis Xenograft Model Antitumor Assays Radiation Monitoring Neoplasm Staging Survival Analysis Survival Rate Molecular Targeted Therapy Clinical Trials, Phase I as Topic Clinical Trials, Phase III as Topic Radiotherapy Neoadjuvant Therapy Drug Delivery Systems Clinical Trials, Phase II as Topic Immunotherapy Follow-Up Studies Radiotherapy Dosage Drug Carriers Inhibitory Concentration 50 Radiation Injuries, Experimental Randomized Controlled Trials as Topic Radiotherapy, Adjuvant Prospective Studies Induction Chemotherapy Retrospective Studies Random Allocation Neoplasm Transplantation Flow Cytometry Neoplasms, Experimental Drug Design Radiometry Drug Evaluation, Preclinical Salvage Therapy Dose Fractionation Risk Factors Remission Induction Chemotherapy, Cancer, Regional Perfusion Tumor Burden Hyperthermia, Induced Radiotherapy, Conformal Transplantation, Heterologous Blotting, Western Transplantation, Autologous Cytotoxicity Tests, Immunologic Kaplan-Meier Estimate Chemoradiotherapy Models, Biological Cranial Irradiation Drug Therapy, Combination Nanocapsules Tomography, X-Ray Computed Drug Discovery Radiotherapy, Intensity-Modulated Immunohistochemistry Infusions, Intravenous Transfection Palliative Care Infusions, Intra-Arterial Brachytherapy Tumor Stem Cell Assay Drug Therapy

Phenomena and Processes34

Radiation Dosage Radiation, Ionizing Drug Resistance, Neoplasm Dose-Response Relationship, Radiation Apoptosis Radiation Tolerance Cell Survival Radiation Drug Synergism Time Factors Dose-Response Relationship, Drug Cell Proliferation Gene Expression Regulation, Neoplastic DNA Damage Gamma Rays Cytotoxicity, Immunologic Inhibitory Concentration 50 Drug Resistance, Multiple Cosmic Radiation Signal Transduction Molecular Structure Cell Cycle Background Radiation Ultraviolet Rays Cell Death Radiation Effects Cell Division DNA Repair Drug Resistance Structure-Activity Relationship Mutation X-Rays Transfection Genes, MDR

Disciplines and Occupations6

Radiation Oncology Drug Design Nanomedicine Drug Discovery Immunohistochemistry Medical Oncology

Technology, Industry, Agriculture3

Nanoparticles Nanomedicine Nanocapsules

Information Science4

Survival Rate Radiotherapy, Conformal Molecular Sequence Data Radiotherapy, Intensity-Modulated

Health Care26

Radiation Dosage Radiation Injuries Treatment Outcome Dose-Response Relationship, Radiation Clinical Trials as Topic Disease-Free Survival Radiation Protection Radiation Monitoring Survival Analysis Survival Rate Clinical Trials, Phase I as Topic Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Follow-Up Studies Radiation Injuries, Experimental Cosmic Radiation Randomized Controlled Trials as Topic Prospective Studies Retrospective Studies Ultraviolet Rays Random Allocation Radiation Effects Risk Factors Kaplan-Meier Estimate Acute Radiation Syndrome Palliative Care

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents Doxorubicin Chemotherapy, Adjuvant Neoplasms Combined Modality Therapy Radiation Dosage Radiation, Ionizing Cisplatin Cyclophosphamide Cell Line, Tumor Drug Resistance, Neoplasm Radiation Injuries T-Lymphocytes, Cytotoxic Breast Neoplasms Treatment Outcome Etoposide Drug Screening Assays, Antitumor Antibiotics, Antineoplastic Dose-Response Relationship, Radiation Apoptosis Radiation Tolerance Lung Neoplasms Cell Survival Radiation Clinical Trials as Topic Paclitaxel Disease-Free Survival Drug Administration Schedule Prognosis Antineoplastic Agents, Phytogenic Methotrexate Angiogenesis Inhibitors Radiation Protection Antimetabolites, Antineoplastic Xenograft Model Antitumor Assays Deoxycytidine Tumor Cells, Cultured Radiation Monitoring Drug Synergism Neoplasm Staging Survival Analysis Time Factors Organoplatinum Compounds Survival Rate Taxoids Neoplasm Recurrence, Local Mice, Nude Neutropenia Dose-Response Relationship, Drug Molecular Targeted Therapy Ovarian Neoplasms Lymphoma, Non-Hodgkin Mitoxantrone Antibodies, Monoclonal, Humanized Cell Proliferation Neoplasm Metastasis Clinical Trials, Phase I as Topic Antibodies, Monoclonal Carcinoma, Non-Small-Cell Lung Dacarbazine Clinical Trials, Phase III as Topic Brain Neoplasms Acneiform Eruptions Adenocarcinoma Fluorouracil Radiotherapy Vincristine Neoadjuvant Therapy Drug Delivery Systems Vinblastine Camptothecin Radiation Oncology Lymphoma Protein Kinase Inhibitors Clinical Trials, Phase II as Topic Antineoplastic Agents, Alkylating Immunotherapy Carboplatin Follow-Up Studies Leukemia, Myeloid, Acute Gene Expression Regulation, Neoplastic Radiotherapy Dosage DNA Damage Niacinamide Bleomycin Liver Neoplasms Drug Carriers Benzenesulfonates Gamma Rays Cytotoxicity, Immunologic Inhibitory Concentration 50 Tumor Markers, Biological Bone Marrow Radiation-Sensitizing Agents Thrombocytopenia Granulocyte Colony-Stimulating Factor Drug Resistance, Multiple P-Glycoprotein Radiation Pneumonitis

No FAQ available that match "cytotoxic chemotherapy genetic anticancer drugs or radiation"